An overview of ethologicall-based animal models suitable for investigating the
pharmacological treatment of anxiety disorders is presented. The DSM-IIIR classification …

Studies on alcoholic patients have found a higher than expected prevalence of panic
disorder, and suggest a positive correlation between the level of alcohol consumption and …

This article is the presentation of the main phobia data from the Epidemiologic Catchment
Area (ECA) program, with a sample size of n= 18,571. Work on this article was initiated in …

The human pharmacology of anxiety disorders, including panic disorder, is detailed. The
major theories center around the role of benzodiazepine receptor, noradrenergic and …

Twenty-five patients with a primary DSM-III-R diagnosis of panic disorder with or without
agoraphobia were treated openly with the serotonin uptake inhibitor fluoxetine for up to 12 …

Adults in a village in Lesotho, Africa, were interviewed to determine the community
prevalence of major depression, panic disorder, and generalised anxiety disorder. The …

In addition to being effective in depressive disorders, monoamine oxidase inhibitors (MAOIs)
have been shown to be effective in controlled studies of patient with panic disorder with …

Seventy-nine patients with panic disorder were randomized to an 8-week double-blind
treatment with alprazolam, imipramine, or placebo. Patients kept daily records of panic …

This article addresses the question: what is the most productive way to systemize abnormal
behavior in order to study its biological roots? Though nosplogy still occupies the premier …

Anxiogenic challenge studies (intravenous lactate infusion and oral fenfluramine challenge)
were conducted in 17 patients with panic disorder (PD), 12 patients with major depressive …